SCHEMBL578024

SCHEMBL578024

Fc1[c]nc2ccccc2c1-c1nc(C(F)(F)F)cs1

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 1/20 0.32
ESR1 P03372 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
TGFBR1 P36897 1/20 0.30
BACE1 P56817 1/20 0.30
IDH1 O75874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL577867 0.83 MEN1 (0.33) TLR7
SCHEMBL578025 0.82 TLR7 (0.32) TLR7ADORA2AADORA1TGFBR1BACE1
SCHEMBL578213 0.80 TACR1 (0.34) TLR7
SCHEMBL576843 0.78 CCR4 (0.38)
SCHEMBL577742 0.76 MAPT (0.41) TLR7
SCHEMBL577868 0.75 POLB (0.40) TLR7
SCHEMBL3724060 0.73 IDH1 (0.31) TLR7ADORA2AADORA1IDH1
SCHEMBL30310815 0.69 MPL (0.47) ADORA2AADORA1TGFBR1IDH1
SCHEMBL1232518 0.68 ELANE (0.38)
SCHEMBL2083581 0.67 KDM4E (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2461811-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX Pharmaceuticals, Inc. (US) 2012-06-13 EP disclosed
EP-2417134-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX Pharmaceuticals, Inc. (US) 2012-02-15 EP disclosed
WO-2011017389-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV IDENIX PHARMACEUTICALS, INC. (US) 2011-02-10 WO disclosed
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed